CliffBio
small molecule

HYDRO-RIDE

AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

Loss of exclusivity—loss of exclusivity
CompanyPar →See this company's full patent-cliff portfolio

Drug detail

Brand nameHYDRO-RIDE
Active ingredientAMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
StrengthEQ 5MG ANHYDROUS;50MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalDecember 1990
Marketing statusDISCN

More from Par

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

HYDRO-RIDE patent cliff — loss of exclusivity — | CliffBio